Li Zhang Selected Research

Cisplatin (Platino)

4/2024	Ganoderma spore lipid ameliorates docetaxel, cisplatin, and 5-fluorouracil chemotherapy-induced damage to bone marrow mesenchymal stem cells and hematopoiesis.
4/2024	4-octyl itaconate alleviates cisplatin-induced ferroptosis possibly via activating the NRF2/HO-1 signalling pathway.
1/2024	Nobiletin alleviates cisplatin-induced ototoxicity via activating autophagy and inhibiting NRF2/GPX4-mediated ferroptosis.
1/2024	Agrimol B alleviates cisplatin-induced acute kidney injury by activating the Sirt1/Nrf2 signaling pathway in mice.
10/2023	TAOK3 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance Through Augmenting Autophagy Mediated by IRGM.
3/2023	Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia.
3/2023	Ribosome Biogenesis Regulator 1 Homolog (RRS1) Promotes Cisplatin Resistance by Regulating AEG-1 Abundance in Breast Cancer Cells.
1/2023	Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial.
1/2023	Validation of different personalized risk models of chemotherapy-induced nausea and vomiting: results of a randomized, double-blind, phase III trial of fosaprepitant for cancer patients treated with high-dose cisplatin.
1/2023	A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li Zhang Research Topics

Disease

1538	Neoplasms (Cancer) 12/2024 - 03/2002
389	Inflammation (Inflammations) 12/2024 - 10/2002
359	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 10/2003
278	Infections 04/2024 - 08/2003
234	Neoplasm Metastasis (Metastasis) 05/2024 - 03/2002
154	Lung Neoplasms (Lung Cancer) 05/2024 - 06/2002
152	Breast Neoplasms (Breast Cancer) 03/2024 - 08/2004
132	Stroke (Strokes) 01/2025 - 04/2002
125	Hypoxia (Hypoxemia) 12/2024 - 03/2002
125	Carcinogenesis 02/2024 - 08/2002
118	Fibrosis (Cirrhosis) 04/2024 - 08/2002
116	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2001
105	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 06/2005
98	Body Weight (Weight, Body) 12/2024 - 01/2003
97	Ischemia 12/2024 - 04/2002
97	Stomach Neoplasms (Stomach Cancer) 05/2024 - 03/2005
96	Pain (Aches) 12/2024 - 07/2007
84	Wounds and Injuries (Trauma) 08/2024 - 03/2004
84	Carcinoma (Carcinomatosis) 12/2023 - 06/2002
78	COVID-19 07/2024 - 01/2020
78	Hypertension (High Blood Pressure) 04/2024 - 10/2003
77	Disease Progression 05/2024 - 08/2005
77	Adenocarcinoma of Lung 04/2024 - 04/2007
74	Nasopharyngeal Carcinoma 01/2023 - 08/2002
72	Glioma (Gliomas) 05/2024 - 02/2005
71	Insulin Resistance 05/2024 - 05/2004
71	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 04/2005
69	Type 2 Diabetes Mellitus (MODY) 05/2024 - 09/2004
68	Parkinson Disease (Parkinson's Disease) 03/2024 - 02/2004
67	Infarction (Infarctions) 01/2025 - 02/2002
65	Sepsis (Septicemia) 04/2024 - 06/2004
62	Obesity 05/2024 - 09/2004
62	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 10/2004
62	Myocardial Infarction 04/2024 - 05/2003
62	Reperfusion Injury 02/2024 - 04/2003
59	Necrosis 01/2024 - 01/2003
57	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 11/2010
56	Hemorrhage 03/2024 - 04/2003
56	Non-alcoholic Fatty Liver Disease 11/2023 - 05/2011
54	Pneumonia (Pneumonitis) 04/2024 - 02/2010
51	Brain Ischemia (Cerebral Ischemia) 02/2024 - 04/2002
50	Ischemic Stroke 01/2025 - 08/2004
49	Leukemia 01/2024 - 07/2004
48	Adenocarcinoma 11/2023 - 06/2002
47	Cognitive Dysfunction 01/2024 - 04/2011
46	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 12/2008
45	Melanoma (Melanoma, Malignant) 01/2024 - 12/2003
45	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 03/2005
44	Atherosclerosis 01/2023 - 11/2002
43	Heart Failure 12/2024 - 02/2004

Drug/Important Bio-Agent (IBA)

564	Proteins (Proteins, Gene)FDA Link 01/2025 - 04/2002
312	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2005
180	CytokinesIBA 05/2024 - 01/2003
168	MicroRNAs (MicroRNA)IBA 01/2025 - 10/2010
158	Messenger RNA (mRNA)IBA 12/2024 - 04/2002
136	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 09/2004
134	LipidsIBA 04/2024 - 08/2004
132	Immune Checkpoint InhibitorsIBA 05/2024 - 06/2015
118	ErbB Receptors (EGF Receptor)IBA 01/2024 - 11/2002
113	RNA (Ribonucleic Acid)IBA 05/2024 - 05/2009
109	Therapeutic UsesIBA 01/2025 - 02/2004
107	Long Noncoding RNAIBA 04/2024 - 05/2014
102	EnzymesIBA 03/2024 - 01/2003
97	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 08/2002
86	Peptides (Polypeptides)IBA 04/2024 - 05/2004
82	LigandsIBA 04/2024 - 12/2002
82	Tyrosine Kinase InhibitorsIBA 01/2024 - 05/2004
77	Interleukin-6 (Interleukin 6)IBA 05/2024 - 01/2003
76	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 04/2002
76	LipopolysaccharidesIBA 04/2024 - 01/2003
75	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 05/2004
74	VaccinesIBA 01/2024 - 05/2004
72	Phosphotransferases (Kinase)IBA 12/2024 - 07/2004
66	Indicators and Reagents (Reagents)IBA 04/2024 - 10/2004
66	Gefitinib (Iressa)FDA Link 01/2024 - 05/2004
65	AntigensIBA 12/2023 - 07/2003
64	Insulin (Novolin)FDA Link 01/2024 - 05/2004
61	AntioxidantsIBA 04/2024 - 06/2003
60	Neuroprotective AgentsIBA 05/2024 - 07/2003
60	Small Interfering RNA (siRNA)IBA 03/2024 - 01/2006
58	AntibodiesIBA 07/2024 - 03/2004
58	Transcription Factors (Transcription Factor)IBA 02/2024 - 10/2004
56	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 12/2004
54	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 06/2005
53	CholesterolIBA 04/2024 - 11/2002
51	CollagenIBA 04/2024 - 04/2005
51	Oxygen (Dioxygen)IBA 03/2024 - 09/2004
46	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024 - 01/2003
45	Triglycerides (Triacylglycerol)IBA 04/2024 - 05/2002
44	PlatinumIBA 03/2024 - 07/2004
44	CateninsIBA 01/2024 - 01/2010
43	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 08/2011
43	Monoclonal AntibodiesIBA 01/2024 - 03/2004

Therapy/Procedure

910	Therapeutics 08/2024 - 02/2003
357	Drug Therapy (Chemotherapy) 04/2024 - 12/2002
164	Immunotherapy 05/2024 - 02/2004
121	Radiotherapy 03/2024 - 08/2002
82	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 11/2003
62	Aftercare (After-Treatment) 05/2024 - 04/2002
55	Lasers (Laser) 12/2023 - 06/2002